Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K, Weidler S, Bereznicka A, Mikolajczyk K, Kaczmarek R, Bednarz B, Zhang T, Urbaniak A, Olczak M, Park EY, Majorczyk E, Kapczynska K, Lukasiewicz J, Wuhrer M, Unverzagt C, Czerwinski M. Szymczak-Kulus K, et al. Among authors: bednarz b. J Biol Chem. 2021 Jan-Jun;296:100299. doi: 10.1016/j.jbc.2021.100299. Epub 2021 Jan 15. J Biol Chem. 2021. PMID: 33460651 Free PMC article.
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibition.
Kerr CP, Jin WJ, Liu P, Grudzinski JJ, Ferreira CA, Rojas HC, Oñate AJ, Kwon O, Hyun M, Idrissou MB, Schwartz RW, Vera JM, Clark PA, Takashima M, Erbe AK, Shea AG, Powers M, Pinchuk AN, Massey CF, Choi C, Hernandez R, Bednarz BP, Ong IM, Weichert JP, Morris ZS. Kerr CP, et al. Among authors: bednarz bp. bioRxiv [Preprint]. 2024 Dec 26:2024.12.26.630430. doi: 10.1101/2024.12.26.630430. bioRxiv. 2024. PMID: 39763914 Free PMC article. Preprint.
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.
Bruce JY, Burr A, Kimple RJ, Adam DP, Yu M, Piaskowski SM, Glazer TA, Hill P, Hartig GK, McCulloch TM, Wieland AM, Trask D, Oliver K, Longcor J, Rogus-Pulia N, Cho SY, Bednarz B, Harari PM. Bruce JY, et al. Among authors: bednarz b. EBioMedicine. 2024 Dec 12;111:105496. doi: 10.1016/j.ebiom.2024.105496. Online ahead of print. EBioMedicine. 2024. PMID: 39671752 Free PMC article.
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models.
Kerr CP, Sheehan-Klenk J, Grudzinski JJ, Adam DP, Nguyen TPT, Ferreira CA, Bates AM, Jin WJ, Kwon O, Olson AP, Lin W, Hyun M, Jagodinsky JC, Powers M, Sriramaneni RN, Clark PA, Shea AG, Rojas HC, Choi C, Massey CF, Zangl LM, Pinchuk AN, Aluicio-Sarduy E, Kim K, Engle JW, Hernandez R, Bednarz BP, Weichert JP, Morris ZS. Kerr CP, et al. Among authors: bednarz bp. bioRxiv [Preprint]. 2024 Jul 16:2024.07.10.602990. doi: 10.1101/2024.07.10.602990. bioRxiv. 2024. PMID: 39071353 Free PMC article. Preprint.
163 results